Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intervention With Riboflavin to Improve Vascular Health and ENdothelial Functioning in Genetically at- Risk Adults (InteRVENE Study)

NCT05488106 is registered in ClinicalTrials.gov with University of Ulster as lead sponsor.

NCT NCT05488106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05488106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intervention With Riboflavin to Improve Vascular Health and ENdothelial Functioning in Genetically at- Risk Adults (InteRVENE Study)
Lead sponsor
University of Ulster
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2022
Completion date
June 30, 2023
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure, hypertension